Altis Biosystems Private
Altis Biosystems is a biotechnology company that specializes in developing research tools for the pharmaceutical and biotech industries. Their main focus is on creating a patent-pending stem cell technology that recreates the human intestinal epithelium for compound screening and microbiome research. Their organ on a chip product allows for the production of a layer of human or animal intestinal stem and differentiated cells, which can be used for disease modeling, precision medicine, microbiome research, and compound screening. Altis Biosystems aims to provide innovative solutions for drug discovery and development in order to advance the field of biotechnology.
Investors
Technology:
Other
Headquarters:
Others
Funding Status:
Seed
Founded Date:
2015-01-01
Last Funding Type:
Seed
Investors Number:
8
Estimated Revenue:
$1M to $10M
Employee Number:
27
Total Funding:
$3.1M
Industry:
Stem Cells (Regenerative Medicine)
Investor Type:
For Profit